ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Schmidt Approve NCAB Authorizations

February 18, 1977

In Brief: ASCO Letter To Clinton Urges support For Trials; Senator Praises NCI, Bristol; Berlin Back A NCI

January 15, 1993

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981